Nanocargos designed with synthetic and natural polymers for ovarian cancer management.
Bionanotechnology
Nano-enabled drug delivery
Natural polymers
Ovarian cancer
Synthetic polymers
Journal
Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
01
06
2023
accepted:
29
06
2023
medline:
14
11
2023
pubmed:
8
7
2023
entrez:
8
7
2023
Statut:
ppublish
Résumé
Ovarian cancer cells usually spread in the peritoneal region, and if chemotherapeutic drugs can be given in these regions with proximity, then the anticancer property of the chemotherapeutic drugs can enhance. However, chemotherapeutic drug administrations are hindered by local toxicity. In the drug delivery system, microparticles or nanoparticles are administered in a controlled manner. Microparticles stay in a close vicinity while nanoparticles are smaller and can move evenly in the peritoneum. Intravenous administration of the drug evenly distributes the medicine in the target places and if the composition of the drug has nanoparticles it will have more specificity and will have easy access to the cancer cells and tumors. Among the different types of nanoparticles, polymeric nanoparticles were proven as most efficient in drug delivery. Polymeric nanoparticles are seen to be combined with many other molecules like metals, non-metals, lipids, and proteins, which helps in the increase of cellular uptake. The efficiency of different types of polymeric nanoparticles used in delivering the load for management of ovarian cancer will be discussed in this mini-review.
Identifiants
pubmed: 37421430
doi: 10.1007/s00210-023-02608-0
pii: 10.1007/s00210-023-02608-0
doi:
Substances chimiques
Antineoplastic Agents
0
Polymers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3407-3415Subventions
Organisme : Chettinad Academy of Research and Education
ID : 004/Regr./AR-Research/2022-06
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Abriata JP, Turatti RC, Luiz MT et al (2019) Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Mater Sci Eng C Mater Biol Appl 96:347–355. https://doi.org/10.1016/j.msec.2018.11.035
doi: 10.1016/j.msec.2018.11.035
pubmed: 30606542
Alizadeh L, Zarebkohan A, Salehi R, Ajjoolabady A, Rahmati-Yamchi M (2019) Chitosan-based nanotherapeutics for ovarian cancer treatment. J Drug Target 27(8):839–852. https://doi.org/10.1080/1061186X.2018.1564923
doi: 10.1080/1061186X.2018.1564923
pubmed: 30596291
Balasubramanian D, Girigoswami A, Girigoswami K (2022) Antimicrobial, pesticidal and food preservative applications of lemongrass oil nanoemulsion: a mini-review. Recent Adv Food Nutr Agric 13(1):51–58. https://doi.org/10.2174/2212798412666220527154707
doi: 10.2174/2212798412666220527154707
pubmed: 35638282
Balasubramanian D, Girigoswami A, Girigoswami K (2023) Nano resveratrol and its anticancer activity. Curr Appl Sci Technol. https://doi.org/10.55003/cast.2022.03.23.010
Bhattacharya S, Anjum MM, Patel KK (2022) Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery. Drug Deliv 29(1):1060–1074. https://doi.org/10.1080/10717544.2022.2058645
doi: 10.1080/10717544.2022.2058645
pubmed: 35363113
pmcid: 8979509
Bortot B, Mongiat M, Valencic E et al (2020) Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian cancer. Int J Nanomedicine 15:4793–4810. https://doi.org/10.2147/IJN.S247114
doi: 10.2147/IJN.S247114
pubmed: 32764921
pmcid: 7368240
Brandhonneur N, Boucaud Y, Verger A et al (2021) Molybdenum cluster loaded PLGA nanoparticles as efficient tools against epithelial ovarian cancer. Int J Pharm 592:120079. https://doi.org/10.1016/j.ijpharm.2020.120079
doi: 10.1016/j.ijpharm.2020.120079
pubmed: 33189811
Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10(1):4. https://doi.org/10.3390/jfb10010004
doi: 10.3390/jfb10010004
pubmed: 30626094
pmcid: 6463038
Chaurasiya S, Mishra V (2018) Biodegradable nanoparticles as theranostics of ovarian cancer: an overview. J Pharm Pharmacol 70(4):435–449. https://doi.org/10.1111/jphp.12860
doi: 10.1111/jphp.12860
pubmed: 29380366
Duse L, Agel MR, Pinnapireddy SR et al (2019) Photodynamic therapy of ovarian carcinoma cells with curcumin-loaded biodegradable polymeric nanoparticles. Pharmaceutics 11(6):282. https://doi.org/10.3390/pharmaceutics11060282
doi: 10.3390/pharmaceutics11060282
pubmed: 31208085
pmcid: 6630253
Esim O, Gedik ME, Dogan AL, Gunaydin G, Hascicek C (2021) Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line. J. Drug Deliv Sci Technol 64:102655. https://doi.org/10.1016/j.jddst.2021.102655
doi: 10.1016/j.jddst.2021.102655
Faramarzi L, Dadashpour M, Sadeghzadeh H, Mahdavi M, Zarghami N (2019) Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells. Artif Cells Nanomed Biotechnol 47(1):737–746. https://doi.org/10.1080/21691401.2019.1573737
doi: 10.1080/21691401.2019.1573737
pubmed: 30892093
Firouzai-Amandi A, Tarahomi M, RahmaniYoushanlouie H et al (2022) Development, characterization, and in vitro evaluation of cytotoxic activity of rutin loaded PCL-PEG nanoparticles against Skov3 ovarian cancer cell. Asian Pac J Cancer Prev 23(6):1951–1957. https://doi.org/10.31557/APJCP.2022.23.6.1951
doi: 10.31557/APJCP.2022.23.6.1951
pubmed: 35763636
Fraguas-Sánchez AI, Torres-Suárez AI, Cohen M et al (2020) PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: in vitro and in ovo assessment. Pharmaceutics 12(5):439. https://doi.org/10.3390/pharmaceutics12050439
doi: 10.3390/pharmaceutics12050439
pubmed: 32397428
pmcid: 7285054
Gagliardi A, Giuliano E, Venkateswararao E et al (2021) Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol 12:601626. https://doi.org/10.3389/fphar.2021.601626
doi: 10.3389/fphar.2021.601626
pubmed: 33613290
pmcid: 7887387
Gawde KA, Sau S, Tatiparti K et al (2018) Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Colloids Surf B 167:8–19. https://doi.org/10.1016/j.colsurfb.2018.03.046
doi: 10.1016/j.colsurfb.2018.03.046
Geeva Narayan S (2022) Insight into the preparation of biopolymeric nanoparticles with lithium and their cellular uptake studies using PC 12 cells. Mater Res Innov 26(7):415–26. https://doi.org/10.1080/14328917.2021.2023288
doi: 10.1080/14328917.2021.2023288
Girigoswami K, Pallavi P, Girigoswami A (2020) Targeting cancer stem cells by nanoenabled drug delivery. Cancer Cell Int 313–37. https://doi.org/10.1007/978-981-15-5120-8_17
Girigoswami K, Girigoswami A (2021) A review on the role of nanosensors in detecting cellular miRNA expression in colorectal cancer. Endocr Metab Immune Disord Drug Targets 21(1):12–26. https://doi.org/10.2174/1871530320666200515115723
doi: 10.2174/1871530320666200515115723
pubmed: 32410567
Haribabu V, Sharmiladevi P, Akhtar N, Farook AS, Girigoswami K, Girigoswami A (2019) Label free ultrasmall fluoromagnetic ferrite-clusters for targeted cancer imaging and drug delivery. Curr Drug Deliv 16(3):233–241. https://doi.org/10.2174/1567201816666181119112410
doi: 10.2174/1567201816666181119112410
pubmed: 30451110
Hou P, Kuang H, Deng W, Lei Y (2022) Immobilized copper nanoparticles on biodegradable magnetic starch composite: investigation of its ovarian cancer, cytotoxicity, and antioxidant effects. J Exp Nanosci 17(1):496–508. https://doi.org/10.1080/17458080.2022.2110241
doi: 10.1080/17458080.2022.2110241
Indoria S, Singh V, Hsieh M-F (2020) Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review. Int J Pharm 582:119314. https://doi.org/10.1016/j.ijpharm.2020.119314
doi: 10.1016/j.ijpharm.2020.119314
pubmed: 32283197
Iyshwarya B, Mohammed V, Veerabathiran R (2021) Genetics of endometriosis and its association with ovarian cancer. Clin Obstet Gynecol 1(4):177–185. https://doi.org/10.1016/j.gocm.2021.09.001
doi: 10.1016/j.gocm.2021.09.001
Ji N, Dong C, Jiang J (2022) Evaluation of antioxidant, cytotoxicity, and anti-ovarian cancer properties of the Fe3O4@ CS-starch/Cu bio-nanocomposite. Inorg Chem Commun 140:109452. https://doi.org/10.1016/j.inoche.2022.109452
doi: 10.1016/j.inoche.2022.109452
Jiang H, Liang G, Dai M et al (2020) Preparation of doxorubicin-loaded collagen-PAPBA nanoparticles and their anticancer efficacy in ovarian cancer. Ann Transl Med 8(14):880. https://doi.org/10.21037/atm-20-5028
doi: 10.21037/atm-20-5028
pubmed: 32793724
pmcid: 7396794
Jiang Z, Feng X, Zou H, Xu W, Zhuang X (2021) Poly(l-glutamic acid)-cisplatin nanoformulations with detachable PEGylation for prolonged circulation half-life and enhanced cell internalization. Bioact Mater 6(9):2688–2697. https://doi.org/10.1016/j.bioactmat.2021.01.034
doi: 10.1016/j.bioactmat.2021.01.034
pubmed: 33665501
pmcid: 7895728
Joshi M, Nagarsenkar M, Prabhakar B (2020) Albumin nanocarriers for pulmonary drug delivery: an attractive approach. J Drug Deliv Sci Technol 56:101529. https://doi.org/10.1016/j.jddst.2020.101529
doi: 10.1016/j.jddst.2020.101529
Kim J, Shim MK, Cho Y-J et al (2021) The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis. Biomaterials. 279:121189. https://doi.org/10.1016/j.biomaterials.2021.121189
doi: 10.1016/j.biomaterials.2021.121189
pubmed: 34695659
Levit SL, Tang C (2021) Polymeric nanoparticle delivery of combination therapy with synergistic effects in ovarian cancer. Nanomaterials 11(4):1048. https://doi.org/10.3390/nano11041048
doi: 10.3390/nano11041048
pubmed: 33923947
pmcid: 8072532
Li Y, Gao Y, Zhang X, Guo H, Gao H (2020) Nanoparticles in precision medicine for ovarian cancer: from chemotherapy to immunotherapy. Int J Pharm 591:119986. https://doi.org/10.1016/j.ijpharm.2020.119986
doi: 10.1016/j.ijpharm.2020.119986
pubmed: 33069895
Luiz MT, Abriata JP, Raspantini GL et al (2019) In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Mater Sci Eng C Mater Biol Appl 105:110038. https://doi.org/10.1016/j.msec.2019.110038
doi: 10.1016/j.msec.2019.110038
pubmed: 31546359
Metkar SK, Girigoswami K (2019) Diagnostic biosensors in medicine–a review. Biocatal Agric Biotechnol 17:271–283. https://doi.org/10.1016/j.bcab.2018.11.029
doi: 10.1016/j.bcab.2018.11.029
Mirnezami SMS, Heydarinasab A, Akbarzadehkhyavi A, Adrjmand M (2021) Development and optimization of lipid-polymer hybrid nanoparticles containing melphalan using central composite design and its effect on ovarian cancer cell lines. Iran. J. Pharm. Res. 20(4):213–228. https://doi.org/10.22037/ijpr.2021.114575.14923
doi: 10.22037/ijpr.2021.114575.14923
pubmed: 35194441
pmcid: 8842616
Moammeri A, Abbaspour K, Zafarian A et al (2022) pH-responsive, adorned nanoniosomes for codelivery of cisplatin and epirubicin: synergistic treatment of breast cancer. ACS Appl Bio Mater 5(2):675–690. https://doi.org/10.1021/acsabm.1c01107
doi: 10.1021/acsabm.1c01107
pubmed: 35129960
pmcid: 8864616
Padhi S, Kapoor R, Verma D, Panda AK, Iqbal Z (2018) Formulation and optimization of topotecan nanoparticles: in vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B 183:222–232. https://doi.org/10.1016/j.jphotobiol.2018.04.022
doi: 10.1016/j.jphotobiol.2018.04.022
pubmed: 29729631
Pallavi P, Sharmiladevi P, Haribabu V, Girigoswami K, Girigoswami A (2022) A nano approach to formulate photosensitizers for photodynamic therapy. Curr Nanosci 18(6):675–689. https://doi.org/10.2174/1573413718666211222162041
doi: 10.2174/1573413718666211222162041
Pallavi P, Harini K, Crowder S et al (2023) Rhodamine-conjugated anti-Stokes gold nanoparticles with higher ROS quantum yield as theranostic probe to arrest cancer and MDR bacteria. Appl Biochem Biotechnol. https://doi.org/10.1007/s12010-023-04475-0
doi: 10.1007/s12010-023-04475-0
pubmed: 36976503
Pan Q, Tian J, Zhu H et al (2020) Tumor-targeting polycaprolactone nanoparticles with codelivery of paclitaxel and IR780 for combinational therapy of drug-resistant ovarian cancer. ACS Biomater Sci Eng 6(4):2175–2185. https://doi.org/10.1021/acsbiomaterials.0c00163
doi: 10.1021/acsbiomaterials.0c00163
pubmed: 33455308
Patil GB, Borse DM, More MP, Patil DA (2022) Gossypol-embedded casein nanoparticles for potential targeting of ovarian cancer: formulation, characterization, and anticancer activity. J Pharm Innov. https://doi.org/10.1007/s12247-022-09666-6
doi: 10.1007/s12247-022-09666-6
Potara M, Nagy-Simon T, Focsan M et al (2021) Folate-targeted pluronic-chitosan nanocapsules loaded with IR780 for near-infrared fluorescence imaging and photothermal-photodynamic therapy of ovarian cancer. Colloids Surf B 203:111755. https://doi.org/10.1016/j.colsurfb.2021.111755
doi: 10.1016/j.colsurfb.2021.111755
Sun CC, Bodurka DC, Donato ML et al (2002) Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol 87(1):118–128. https://doi.org/10.1006/gyno.2002.6807
doi: 10.1006/gyno.2002.6807
pubmed: 12468352
Sun Z, Duan R, Xing D, Pang X, Li Z, Chen X (2017) Recent advances in application of poly-epsilon-caprolactone and its derivative copolymers for controlled release of anti-tumor drugs. Curr Cancer Drug Targets 17(5):445–455. https://doi.org/10.2174/1568009617666170109150430
doi: 10.2174/1568009617666170109150430
pubmed: 28067177
Taheri-Ledari R, Zolfaghari E, Zarei-Shokat S, Kashtiaray A, Maleki A (2022) A magnetic antibody-conjugated nano-system for selective delivery of Ca(OH)2 and taxotere in ovarian cancer cells. Commun Biol 5(1):995. https://doi.org/10.1038/s42003-022-03966-w
doi: 10.1038/s42003-022-03966-w
pubmed: 36130999
pmcid: 9492675
Vandghanooni S, Eskandani M, Barar J, Omidi Y (2020) Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells. Int J Pharm 573:118729. https://doi.org/10.1016/j.ijpharm.2019.118729
doi: 10.1016/j.ijpharm.2019.118729
pubmed: 31705975
Yang L, Zhang Y, Yang H, Yu L, Rohani S (2022) Evaluation of cytotoxicity and anti-angiogenesis induced by crocetin-delivering alginate hydrogel/chitosan nanoparticle carrier system on human ovarian cancer cell line (A2780): an in vitro evaluation. J Biomed Nanotechnol 18(7):1746–1754. https://doi.org/10.1166/jbn.2022.3384
doi: 10.1166/jbn.2022.3384
Zafar A, Alruwaili NK, Imam SS et al (2021) Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: a review. J Drug Deliv Sci Technol 61:102198. https://doi.org/10.2174/1573413718666211222162041
doi: 10.2174/1573413718666211222162041
Zheng W, Li M, Lin Y, Zhan X (2018) Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer. Biomed Pharmacother 108:565–573. https://doi.org/10.1016/j.biopha.2018.09.039
doi: 10.1016/j.biopha.2018.09.039
pubmed: 30243090